NLRC4-/- mice with NAFLD also had decreased TAMs and decreased IL-1β and VEGF expression, suggesting that NLRC4 plays a key role in the growth and recurrence of liver metastases in the context of both NAFLD and colorectal cancer (62) (Figure 3E). Here, VEGFA is linked to metabolic dysfunction-associated steatotic liver disease.